Clinical Trial

Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2019 (before its estimated November 30, 2020 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this post market clinical study is to evaluate the effectiveness and safety of the Paragon CRT®100 Contact Lens.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-12-04; most recent amendment 2022-08-25.
Status change: Recruiting → Completed 2022-04-11
Trial Details
NCT Number NCT04187599
Lead Sponsor CooperVision International Limited (CVIL)
Collaborators: TigerMed
Conditions Myopia
Enrollment 250 participants
Start Date 2019-08-29
Primary Completion 2020-11-30 (estimated)
Study Completion 2020-12-31 (estimated)
Updated on ClinicalTrials.gov 2019-12-05